Byondis
José Soetekouw possesses extensive experience in quality control and analytical chemistry, having held leadership roles in several prominent organizations. Notably, José serves as the Group Leader of Quality Control - Analytical Chemistry at Byondis and previously led laboratory teams at Danone Nutricia Early Life Nutrition. Additional experience includes being a Group Leader for Analytical Support of Pharmaceutical Products and serving as a Senior Scientist at Merck Sharp & Dohme. José started the professional journey as a Chemical Analyst at Schering-Plough Research Institute. Educational qualifications include a Bachelor’s degree in Analytical Chemistry from HAN University of Applied Sciences and an initial year of study in Analytical Chemistry at Fontys University of Applied Sciences.
This person is not in any teams
Byondis
1 followers
With a passion for outsmarting relentless cancers and autoimmune diseases, Byondis takes precision medicines to the next level. We are driven by one goal: providing novel treatments with high efficacy and low systemic toxicity for patients with high unmet medical needs. Many companies work in the areas of unmet need. What differentiates Byondis is its focus on producing a broad spectrum of molecular concepts, ranging from small molecule chemistries to complex protein structures. We engineer smaller and larger molecular functionalities that may be combined to target the right part of the body. This involves: • Next generation antibody-drug conjugates (ADCs), including proprietary linker-drug (LD) technology to generate multiple ADC candidates targeting different indications • Site-specific conjugation technology • Monoclonal antibodies (mAbs) • Highly selective, disease-targeting small molecules The success of our company fully depends on our people. To them, we aim to provide a fair, open and inspiring working environment, where there is room for ambition, entrepreneurship and new initiatives leading to new medicines that save and transform patients’ lives.